Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., University of Pennsylvania 2014
  • B.S., Bucknell University 2009
• Research
• 

  Selected Grants

  • Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory awarded by Department of Defense 2021 - 2025
  • Defining a CXCR3-associated gene signature as a predictive biomarker and alternate target of immunotherapy across molecular subtypes of breast cancer awarded by National Institutes of Health 2022 - 2025
  • Beyond PD1: An immunotherapeutic strategy to stimulate and enable both T-cell and B-cell responses in immunosuppressive and non-mutated metastatic breast cancer awarded by Department of Defense 2020 - 2024
  • Immunotherapeutic Targeting of a Therapy Resistant Oncogenic HER2 Isoform awarded by Susan G. Komen Breast Cancer Foundation 2017 - 2020
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Kung, Che-Pei, Meghan B. Skiba, Erika J. Crosby, Jessica Gorzelitz, Mary A. Kennedy, Bethany A. Kerr, Yun Rose Li, et al. “Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022.” J Natl Cancer Inst Monogr 2023, no. 61 (May 4, 2023): 149–57. https://doi.org/10.1093/jncimonographs/lgad005.
       Full Text  Link to Item
    • Morse, Michael A., Erika J. Crosby, Jeremy Force, Takuya Osada, Amy C. Hobeika, Zachary C. Hartman, Peter Berglund, Jonathan Smith, and H Kim Lyerly. “Clinical trials of self-replicating RNA-based cancer vaccines.” Cancer Gene Ther, February 10, 2023, 1–9. https://doi.org/10.1038/s41417-023-00587-1.
       Full Text  Link to Item
    • Dailey, Gabrielle P., Erika J. Crosby, and Zachary C. Hartman. “Cancer vaccine strategies using self-replicating RNA viral platforms.” Cancer Gene Ther, July 12, 2022, 1–9. https://doi.org/10.1038/s41417-022-00499-6.
       Full Text  Link to Item
    • Tsao, Li-Chung, Erika J. Crosby, Timothy N. Trotter, Junping Wei, Tao Wang, Xiao Yang, Amanda N. Summers, et al. “Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis.” Jci Insight 7, no. 6 (March 22, 2022). https://doi.org/10.1172/jci.insight.155636.
       Full Text  Link to Item
    • Abe, Shinya, Hiroshi Nagata, Erika J. Crosby, Yoshiyuki Inoue, Kensuke Kaneko, Cong-Xiao Liu, Xiao Yang, et al. “Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.” J Immunother Cancer 10, no. 1 (January 2022). https://doi.org/10.1136/jitc-2021-003717.
       Full Text  Link to Item
    • Osada, Takuya, Erika J. Crosby, Kensuke Kaneko, Joshua C. Snyder, Joshua D. Ginzel, Chaitanya R. Acharya, Xiao-Yi Yang, et al. “HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.” Mol Cancer Ther 21, no. 1 (January 2022): 217–26. https://doi.org/10.1158/1535-7163.MCT-21-0334.
       Full Text  Link to Item
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.” Mol Cancer Res 19, no. 10 (October 2021): 1699–1711. https://doi.org/10.1158/1541-7786.MCR-21-0215.
       Full Text  Link to Item
    • Telli, Melinda L., Hiroshi Nagata, Irene Wapnir, Chaitanya R. Acharya, Kaitlin Zablotsky, Bernard A. Fox, Carlo B. Bifulco, et al. “Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy.” Clin Cancer Res 27, no. 9 (May 1, 2021): 2481–93. https://doi.org/10.1158/1078-0432.CCR-20-3944.
       Full Text  Link to Item
    • Crosby, Erika J., H Kim Lyerly, and Zachary C. Hartman. “Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors.” Oncotarget 12, no. 1 (January 5, 2021): 1–3. https://doi.org/10.18632/oncotarget.27861.
       Full Text  Link to Item
    • Crosby, Erika J., Amy C. Hobeika, Donna Niedzwiecki, Christel Rushing, David Hsu, Peter Berglund, Jonathan Smith, et al. “Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio.” J Immunother Cancer 8, no. 2 (November 2020). https://doi.org/10.1136/jitc-2020-001662.
       Full Text  Link to Item
    • Crosby, Erika J., Chaitanya R. Acharya, Anthony-Fayez Haddad, Christopher A. Rabiola, Gangjun Lei, Jun-Ping Wei, Xiao-Yi Yang, et al. “Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.” Clin Cancer Res 26, no. 17 (September 1, 2020): 4670–81. https://doi.org/10.1158/1078-0432.CCR-20-0389.
       Full Text  Link to Item
    • Tsao, Li-Chung, Erika J. Crosby, Timothy N. Trotter, Pankaj Agarwal, Bin-Jin Hwang, Chaitanya Acharya, Casey W. Shuptrine, et al. “CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis.” Jci Insight 4, no. 24 (December 19, 2019). https://doi.org/10.1172/jci.insight.131882.
       Full Text  Link to Item
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study.” Clin Cancer Res 25, no. 9 (May 1, 2019): 2725–36. https://doi.org/10.1158/1078-0432.CCR-18-3102.
       Full Text  Open Access Copy  Link to Item
    • Crosby, Erika J., Junping Wei, Xiao Yi Yang, Gangjun Lei, Tao Wang, Cong-Xiao Liu, Pankaj Agarwal, et al. “Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors.” Oncoimmunology 7, no. 5 (2018): e1421891. https://doi.org/10.1080/2162402X.2017.1421891.
       Full Text  Link to Item
    • Ren, Jun, William R. Gwin, Xinna Zhou, Xiaoli Wang, Hongyan Huang, Ni Jiang, Lei Zhou, et al. “Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.” Oncoimmunology 6, no. 4 (2017): e1264563. https://doi.org/10.1080/2162402X.2016.1264563.
       Full Text  Link to Item
    • Turpin, J., C. Ling, E. J. Crosby, Z. C. Hartman, A. M. Simond, L. A. Chodosh, J. P. Rennhack, et al. “The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.” Oncogene 35, no. 47 (November 24, 2016): 6053–64. https://doi.org/10.1038/onc.2016.129.
       Full Text  Link to Item
    • Gómez, Daniela, Malissa C. Diehl, Erika J. Crosby, Tiffany Weinkopff, and Gudrun F. Debes. “Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation.” J Immunol 195, no. 8 (October 15, 2015): 3531–36. https://doi.org/10.4049/jimmunol.1500626.
       Full Text  Link to Item
    • Crosby, Erika J., Megan Clark, Fernanda O. Novais, E John Wherry, and Phillip Scott. “Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major.” J Immunol 195, no. 7 (October 1, 2015): 3301–10. https://doi.org/10.4049/jimmunol.1500855.
       Full Text  Link to Item
    • Schadler, Keri L., Erika J. Crosby, Alice Yao Zhou, Dong Ha Bhang, Lior Braunstein, Kwan Hyuck Baek, Danielle Crawford, et al. “Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1.” Cancer Res 74, no. 8 (April 15, 2014): 2171–81. https://doi.org/10.1158/0008-5472.CAN-13-0094.
       Full Text  Link to Item
    • Crosby, Erika J., Michael H. Goldschmidt, E John Wherry, and Phillip Scott. “Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection.” Plos Pathog 10, no. 2 (February 2014): e1003970. https://doi.org/10.1371/journal.ppat.1003970.
       Full Text  Link to Item
    • Rakhra, K., P. Bachireddy, T. Zabuawala, R. Zeiser, L. Xu, A. Kopelman, A. C. Fan, et al. “CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation.” Cancer Cell 18, no. 6 (December 14, 2010): 696. https://doi.org/10.1016/j.ccr.2010.12.001.
       Full Text
    • Rakhra, Kavya, Pavan Bachireddy, Tahera Zabuawala, Robert Zeiser, Liwen Xu, Andrew Kopelman, Alice C. Fan, et al. “CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.” Cancer Cell 18, no. 5 (November 16, 2010): 485–98. https://doi.org/10.1016/j.ccr.2010.10.002.
       Full Text  Link to Item

  • Other Articles

    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 6 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526387.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 5 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526390.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526402.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526420.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526414.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary File 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526381.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526411.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526402.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 7 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526384.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 5 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526405.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 7 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526384.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526393.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 6 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526387.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 2 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526417.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 2 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526399.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526393.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 2 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526399.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526411.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary File 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526381.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526396.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Tables 1-5 for scRNAseq marker genes from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526378.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 5 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526405.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526420.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 5 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526390.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Data from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.c.6545072.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526414.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Tables 1-5 for scRNAseq marker genes from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526378.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Supplementary Figure 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526396.v1.
       Full Text
    • Ginzel, Joshua D., Chaitanya R. Acharya, Veronica Lubkov, Hidetoshi Mori, Peter G. Boone, Lauren K. Rochelle, Wendy L. Roberts, et al. “Movie 2 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase,” April 3, 2023. https://doi.org/10.1158/1541-7786.22526417.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S3 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472856.v1.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S4 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472853.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S1 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472862.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Table S1 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472850.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Table S2 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472847.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S2 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472859.v1.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Table S1 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472850.v1.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Data from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.c.6528351.v1.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S4 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472853.v1.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Data from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.c.6528351.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Table S2 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472847.v1.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S3 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472856.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S2 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472859.
       Full Text
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Figure S1 from Vaccine-Induced Memory CD8⁺ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study,” March 31, 2023. https://doi.org/10.1158/1078-0432.22472862.v1.
       Full Text

  • Conference Papers

    • Chen, M., H. Kim, B. Zhang, W. Yang, T. Osada, E. J. Crosby, H. K. Lyerly, and X. Jiang. “Intracorporeal Sonoporation-Induced Drug/Gene Delivery Using a Catheter Ultrasound Transducer.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2022-October, 2022. https://doi.org/10.1109/IUS54386.2022.9958222.
       Full Text
• Teaching & Mentoring
• 

  Recent Courses

  • BIOTRAIN 750: Introduction to Responsible Conduct of Research Concepts 2023
  • BIOTRAIN 751: The Responsible Scientist I 2023
  • BIOTRAIN 753: Data Management and Quality for Biomedical PhD Students 2023
  • BIOTRAIN 754: The Responsible Scientist II 2023
  • BIOTRAIN 755: BIOTRAIN TEACHING ASSISTANT 2023
  • BIOTRAIN 750: Introduction to Responsible Conduct of Research Concepts 2022
  • BIOTRAIN 751: The Responsible Scientist I 2022
  • BIOTRAIN 753: Data Management and Quality for Biomedical PhD Students 2022
  • BIOTRAIN 754: The Responsible Scientist II 2022
  • BIOTRAIN 755: BIOTRAIN TEACHING ASSISTANT 2022
  • BIOTRAIN 750: Introduction to Responsible Conduct of Research Concepts 2021
  • BIOTRAIN 751: The Responsible Scientist I 2021
  • BIOTRAIN 753: Data Management and Quality for Biomedical PhD Students 2021
  • BIOTRAIN 754: The Responsible Scientist II 2021
  • BIOTRAIN 755: BIOTRAIN TEACHING ASSISTANT 2021

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.